The Challenge of Targeting Notch in Hematologic Malignancies
Notch signaling can play oncogenic and tumor suppressor roles depending on cell type. Hematologic malignancies encompass a wide range of transformed cells, and consequently the roles of Notch are diverse in these diseases. For example Notch is a potent T cell oncogene, with >50% of T cell acute l...
Saved in:
Main Authors: | Fiorela N Hernandez Tejada (Author), Jorge R Galvez Silva (Author), Patrick A Zweidler-Mckay (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
by: Zijun Zhao, et al.
Published: (2018) -
HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016) -
Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies From Concept to Practice [Internet]
Published: (2023) -
Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies From Concept to Practice [Internet]
Published: (2023) -
Advances in Hematologic Malignancies
Published: (2019)